Interplay/RB
between/IN
Epigenetics/NNS
and/CC
Genetics/NNS
in/IN
Cancer/NN
./.
====================
Genomic/JJ
instability/NN
,/,
which/WDT
occurs/VBZ
through/IN
both/DT
genetic/JJ
mechanisms/NNS
(/(
underlying/VBG
inheritable/JJ
phenotypic/JJ
variations/NNS
caused/VBD
by/IN
DNA/NN
sequence-dependent/NN
alterations/NNS
,/,
such/JJ
as/IN
mutation/NN
,/,
deletion/NN
,/,
insertion/NN
,/,
inversion/NN
,/,
translocation/NN
,/,
and/CC
chromosomal/JJ
aneuploidy/NN
)/)
and/CC
epigenomic/JJ
aberrations/NNS
(/(
underlying/VBG
inheritable/JJ
phenotypic/JJ
variations/NNS
caused/VBD
by/IN
DNA/NN
sequence-independent/NN
alterations/NNS
caused/VBD
by/IN
a/DT
change/NN
of/IN
chromatin/NN
structure/NN
,/,
such/JJ
as/IN
DNA/NN
methylation/NN
and/CC
histone/NN
modifications/NNS
)/)
,/,
is/VBZ
known/VBN
to/TO
promote/VB
tumorigenesis/NN
and/CC
tumor/NN
progression/NN
./.
====================
Mechanisms/NNS
involve/VBP
both/CC
genomic/JJ
instability/NN
and/CC
epigenomic/JJ
aberrations/NNS
that/IN
lose/VBP
or/CC
gain/NN
the/DT
function/NN
of/IN
genes/NNS
that/WDT
impinge/VBP
on/IN
tumor/NN
suppression/prevention/NN
or/CC
oncogenesis/NN
./.
====================
Growing/VBG
evidence/NN
points/VBZ
to/TO
an/DT
epigenome-wide/NN
disruption/NN
that/IN
involves/VBZ
large-scale/JJ
DNA/NN
hypomethylation/NN
but/CC
specific/JJ
hypermethylation/NN
of/IN
tumor/NN
suppressor/NN
genes/NNS
,/,
large/JJ
blocks/VBZ
of/IN
aberrant/JJ
histone/NN
modifications/NNS
,/,
and/CC
abnormal/JJ
miRNA/NN
expression/NN
profile/NN
./.
====================
Emerging/VBG
molecular/JJ
details/NNS
regarding/VBG
the/DT
modulation/NN
of/IN
these/DT
epigenetic/JJ
events/NNS
in/IN
cancer/NN
are/VBP
used/VBN
to/TO
illustrate/VB
the/DT
alterations/NNS
of/IN
epigenetic/JJ
molecules/NNS
,/,
and/CC
their/PRP$
consequent/JJ
malfunctions/NNS
could/MD
contribute/VB
to/TO
cancer/NN
biology/NN
./.
====================
More/RBR
recently/RB
,/,
intriguing/JJ
evidence/NN
supporting/VBG
that/DT
genetic/JJ
and/CC
epigenetic/JJ
mechanisms/NNS
are/VBP
not/RB
separate/VB
events/NNS
in/IN
cancer/NN
has/VBZ
been/VBN
emerging/VBG
;/:
they/PRP
intertwine/VBP
and/CC
take/VBP
advantage/NN
of/IN
each/DT
other/JJ
during/IN
tumorigenesis/NN
./.
====================
In/IN
addition/NN
,/,
we/PRP
discuss/VBP
the/DT
collusion/NN
between/IN
epigenetics/NNS
and/CC
genetics/NNS
mediated/VBN
by/IN
heterochromatin/NN
protein/NN
1/CD
,/,
a/DT
major/JJ
component/NN
of/IN
heterochromatin/NN
,/,
in/IN
order/NN
to/TO
maintain/VB
genome/NN
integrity/NN
./.
====================
Cancers/NNS
have/VBP
traditionally/RB
been/VBN
accepted/VBN
as/IN
diseases/NNS
that/IN
are/VBP
induced/VBN
by/IN
the/DT
accumulation/NN
of/IN
a/DT
set/NN
of/IN
genetic/JJ
mutations/NNS
that/WDT
have/VBP
been/VBN
considered/VBN
the/DT
major/JJ
causes/VBZ
of/IN
neoplasia/NN
[/(
1/CD
]/)
./.
====================
But/CC
,/,
is/VBZ
genomic/JJ
instability/NN
a/DT
consequence/NN
of/IN
cancer/NN
progression/NN
or/CC
indeed/RB
a/DT
cause/JJ
that/DT
drives/VBZ
cancer/NN
development/NN
?/.
====================
From/IN
about/RB
1902/CD
up/IN
until/IN
now/RB
,/,
the/DT
involvement/NN
of/IN
genomic/JJ
instability/NN
in/IN
tumorigenesis/NN
has/VBZ
long/JJ
been/VBN
the/DT
subjet/NN
of/IN
debate/NN
./.
====================
In/IN
the/DT
beginning/VBG
,/,
Theodor/DT
Boveri/FW
's/POS
work/NN
with/IN
sea/NN
urchins/NNS
showed/VBD
that/IN
all/DT
chromosomes/NNS
are/VBP
required/VBN
for/IN
normal/JJ
development/NN
,/,
known/VBN
as/IN
the/DT
Boveri-Sutton/JJ
chromosome/NN
theory/JJ
./.
====================
He/RB
had/VBD
also/RB
suggested/VBD
in/IN
1902/CD
that/DT
malignant/JJ
tumors/NNS
might/MD
be/VB
the/DT
result/NN
of/IN
a/DT
certain/JJ
abnormal/JJ
condition/NN
of/IN
the/DT
chromosomes/NNS
,/,
which/WDT
may/MD
arise/VB
from/IN
multipolar/JJ
mitosis/NN
./.
====================
In/IN
the/DT
last/JJ
century/NN
,/,
remarkable/JJ
findings/NNS
and/CC
progresses/NNS
in/IN
cancer/NN
research/NN
have/VBP
added/VBN
genomic/JJ
instability/NN
to/TO
the/DT
hallmark/NN
list/NN
of/IN
cancer/NN
./.
====================
Moreover/RB
,/,
genomic/JJ
instability/NN
generates/VBZ
the/DT
genetic/JJ
and/CC
phenotypic/JJ
heterogenicity/NN
and/CC
diversity/NN
that/IN
expedite/VBP
tumorigenesis/NN
and/CC
the/DT
acquisition/NN
of/IN
cancer/NN
hallmarks/NNS
./.
====================
Our/PRP$
genomes/NNS
are/VBP
constantly/RB
threatened/VBN
by/IN
a/DT
number/NN
of/IN
challenges/NNS
that/DT
are/VBP
originating/VBG
from/IN
extracellular/JJ
and/CC
intracellular/JJ
stimuli/NNS
./.
====================
Effective/JJ
cellular/JJ
responses/NNS
to/TO
these/DT
enormous/JJ
genotoxic/JJ
stresses/NNS
are/VBP
acutely/RB
required/VBN
to/TO
maintain/VB
genomic/JJ
integrity/NN
./.
====================
These/DT
stresses/NNS
can/MD
induce/VB
a/DT
variety/NN
of/IN
problems/NNS
in/IN
the/DT
DNA/NN
,/,
such/JJ
as/IN
double-strand/JJ
breaks/NNS
,/,
single-strand/JJ
breaks/NNS
,/,
oxidative/JJ
lesions/NNS
,/,
and/CC
pyrimidine/NN
dimers/NNS
./.
====================
Eukaryotes/NNS
have/VBP
evolved/VBN
elaborate/VB
DNA/NN
damage/NN
response/NN
(/(
DDR/NN
)/)
mechanisms/NNS
to/TO
properly/RB
respond/VBP
to/TO
the/DT
genotoxic/JJ
stresses/NNS
of/IN
these/DT
lesions/NNS
./.
====================
DNA/NN
damage/NN
induces/VBZ
several/JJ
cellular/JJ
responses/NNS
,/,
including/VBG
checkpoint/NN
activation/NN
,/,
DNA/NN
repair/NN
,/,
and/CC
the/DT
triggering/VBG
of/IN
apoptotic/JJ
pathways/NNS
for/IN
irreparable/JJ
DNA/NN
damage/NN
(/(
Fig/NN
./.
====================
1/CD
)/)
./.
====================
Underlying/VBG
these/DT
DDRs/NNS
are/VBP
functions/NNS
of/IN
many/JJ
tumor/NN
suppressors/NNS
,/,
which/WDT
are/VBP
frequently/RB
lost/VBD
in/IN
cancers/NNS
./.
====================
To/TO
keep/VB
the/DT
genome/NN
intact/JJ
,/,
DNA/NN
replication/NN
must/MD
be/VB
carried/VBN
out/RP
without/IN
error/NN
,/,
and/CC
if/IN
there/EX
is/VBZ
a/DT
mistake/NN
,/,
it/PRP
should/MD
be/VB
repaired/VBN
correctly/RB
./.
====================
Also/RB
,/,
to/TO
give/VB
time/NN
for/IN
cells/NNS
to/TO
repair/NN
any/DT
defect/NN
,/,
cells/NNS
must/MD
have/VBP
intact/JJ
checkpoint/NN
responses/NNS
./.
====================
Replicated/VBN
genomes/NNS
must/MD
be/VB
passed/VBN
to/TO
daughter/NN
cells/NNS
without/IN
error/NN
;/:
therefore/RB
,/,
either/CC
miscopying/VBG
or/CC
missegregation/NN
of/IN
chromosomes/NNS
should/MD
be/VB
avoided/VBN
./.
====================
If/IN
these/DT
self-guarding/VBG
machineries/NNS
are/VBP
not/RB
effective/JJ
,/,
cells/NNS
that/WDT
have/VBP
problems/NNS
should/MD
die/VBP
./.
====================
So/RB
,/,
DNA/NN
replication/NN
,/,
DNA/NN
repair/NN
,/,
transcription/NN
,/,
cell/NN
cycle/NN
machinery/NN
,/,
chromosome/NN
segregation/NN
,/,
and/CC
apoptosis/NN
are/VBP
six/CD
domains/NNS
to/TO
keep/VB
genomic/JJ
integrity/NN
./.
====================
Also/RB
,/,
these/DT
DDRs/NNS
are/VBP
coordinately/RB
regulated/VBN
and/CC
work/NN
together/RB
,/,
via/IN
a/DT
series/NN
of/IN
signaling/NN
pathways/NNS
that/WDT
eventually/RB
activate/VBP
surveillance/NN
and/CC
checkpoints/NNS
for/IN
genomic/JJ
integrity/NN
./.
====================
In/IN
other/JJ
words/NNS
,/,
cancer/NN
cells/NNS
have/VBP
problems/NNS
in/IN
these/DT
machineries/NNS
,/,
leading/VBG
to/TO
genomic/JJ
instability/NN
./.
====================
The/DT
word/NN
``/CD
epigenetics/NNS
''/CD
was/VBD
termed/VBN
in/IN
the/DT
early/JJ
1940s/NNS
to/TO
describe/VB
the/DT
events/NNS
that/WDT
could/MD
not/RB
be/VB
wholly/RB
explained/VBN
by/IN
traditional/JJ
genetics/NNS
[/(
2/CD
]/)
./.
====================
Conrad/JJ
Waddington/NN
(/(
1905-1975/CD
)/)
defined/VBN
epigenetics/NNS
as/IN
``/CD
the/DT
branch/NN
of/IN
biology/NN
which/WDT
studies/NNS
the/DT
causal/JJ
interactions/NNS
between/IN
genes/NNS
and/CC
their/PRP$
products/NNS
which/WDT
bring/VBG
the/DT
phenotype/NN
into/IN
being/VBG
''/CD
[/(
3/CD
]/)
./.
====================
The/DT
epigenetic/JJ
field/NN
now/RB
actively/RB
uncovers/NNS
the/DT
molecular/JJ
mechanisms/NNS
underlying/VBG
these/DT
phenomena/NNS
,/,
and/CC
epigenetics/NNS
has/VBZ
been/VBN
defined/VBN
today/RB
as/IN
``/RB
the/DT
study/NN
of/IN
changes/NNS
in/IN
gene/NN
function/NN
that/IN
are/VBP
mitotically/RB
and/or/CC
meiotically/RB
heritable/JJ
and/CC
that/IN
do/VBP
not/RB
entail/VB
a/DT
change/NN
in/IN
DNA/NN
sequence/NN
''/CD
[/(
4/CD
]/)
./.
====================
In/IN
other/JJ
words/NNS
,/,
epigenetics/NNS
is/VBZ
the/DT
study/NN
of/IN
changes/NNS
in/IN
gene/NN
expression/NN
or/CC
phenotype/NN
,/,
caused/VBD
by/IN
mechanisms/NNS
other/JJ
than/IN
DNA/NN
sequences/NNS
,/,
and/CC
some/DT
of/IN
these/DT
epigenetic/JJ
changes/NNS
have/VBP
even/RB
been/VBN
shown/VBN
to/TO
be/VB
heritable.Our/RB
genetic/JJ
information/NN
is/VBZ
stored/VBN
in/IN
the/DT
form/NN
of/IN
DNA/NN
as/IN
genetic/JJ
code/VBP
,/,
but/CC
it/PRP
has/VBZ
to/TO
be/VB
copied/VBN
into/IN
RNA/NN
as/IN
an/DT
intermediate/JJ
messenger/NN
or/CC
non-coding/JJ
functional/JJ
component/NN
./.
====================
This/DT
copying/VBG
process/NN
,/,
transcription/NN
,/,
is/VBZ
regulated/VBN
at/IN
several/JJ
steps/NNS
,/,
including/VBG
initiation/NN
,/,
elongation/NN
,/,
and/CC
termination/NN
,/,
by/IN
a/DT
variety/NN
of/IN
mechanisms/NNS
./.
====================
Moreover/RB
,/,
eukaryotic/JJ
transcription/NN
has/VBZ
to/TO
deal/JJ
with/IN
chromatin/NN
templates/NNS
,/,
such/JJ
that/IN
histone/NN
modifications/NNS
and/CC
chromatin/NN
remodeling/NN
vastly/RB
affect/VB
gene/NN
expression/NN
./.
====================
Several/JJ
types/NNS
of/IN
cancers/NNS
and/CC
genetic/JJ
disorders/NNS
are/VBP
often/RB
associated/VBN
with/IN
abnormal/JJ
transcription/NN
,/,
highlighting/VBG
the/DT
importance/NN
of/IN
regulated/VBN
transcription/NN
in/IN
the/DT
pathology/NN
and/CC
prevention/NN
of/IN
cancers.Part/NN
of/IN
the/DT
genome/NN
has/VBZ
no/DT
transcribed/VBN
information/NN
,/,
which/WDT
,/,
however/RB
,/,
has/VBZ
functional/JJ
roles/NNS
by/IN
various/JJ
mechanisms/NNS
./.
====================
For/IN
example/NN
,/,
cis/NN
elements/NNS
(/(
DNA/NN
sequences/NNS
)/)
can/MD
act/VB
as/IN
regulatory/JJ
elements/NNS
for/IN
transcription/NN
and/CC
replication/NN
./.
====================
Also/RB
,/,
centromeric/JJ
DNA/NN
is/VBZ
required/VBN
for/IN
mitotic/JJ
and/CC
meiotic/JJ
chromatin/NN
structure/NN
,/,
and/CC
telomeric/JJ
DNA/NN
plays/VBZ
a/DT
role/NN
in/IN
sheltering/VBG
the/DT
ends/NNS
of/IN
chromosomes/NNS
and/CC
eventually/RB
guarding/VBG
the/DT
genome/NN
./.
====================
Indeed/RB
,/,
centromeric/JJ
and/CC
telomeric/JJ
heterochromatin/NN
structures/NNS
consist/VBP
of/IN
specific/JJ
repetitive/JJ
sequences/NNS
,/,
which/WDT
play/VBP
a/DT
role/NN
in/IN
maintaining/VBG
genomic/JJ
integrity/NN
,/,
such/JJ
that/IN
heterochromatin/NN
structure/NN
is/VBZ
required/VBN
for/IN
accurate/JJ
chromosome/NN
segregation/NN
(/(
centromere/NN
)/)
and/CC
inhibiting/VBG
DNA/NN
breakages/NNS
and/CC
nonhomologous/JJ
end-joining/JJ
(/(
telomere/RB
)/)
./.
====================
Aneuploidy/DT
and/CC
chromosomal/JJ
rearrangement/NN
,/,
which/WDT
are/VBP
frequently/RB
observed/VBN
in/IN
many/JJ
cancers/NNS
,/,
are/VBP
in/IN
part/NN
caused/VBD
by/IN
aberrant/JJ
chromatin/NN
structure.Generally/RB
,/,
genomic/JJ
instability/NN
is/VBZ
often/RB
associated/VBN
with/IN
cancer/NN
and/CC
can/MD
be/VB
indicative/JJ
of/IN
a/DT
poor/JJ
prognosis/NN
for/IN
some/DT
types/NNS
of/IN
cancer/NN
./.
====================
Lately/RB
,/,
this/DT
concept/NN
has/VBZ
now/RB
been/VBN
expanded/VBN
to/TO
the/DT
field/NN
of/IN
epigenetics/NNS
,/,
and/CC
disorganization/NN
of/IN
epigenetic/JJ
regulatory/JJ
mechanisms/NNS
is/VBZ
prevalent/JJ
in/IN
cancer/NN
[/(
5/CD
,/,
6/CD
]/)
./.
====================
Particular/JJ
gene/NN
expression/NN
is/VBZ
determined/VBN
not/RB
only/RB
by/IN
the/DT
genetic/JJ
status/NN
of/IN
gene/NN
itself/PRP
but/CC
also/RB
by/IN
epigenetic/JJ
features/NNS
,/,
such/JJ
as/IN
promoter/NN
regions/NNS
,/,
enhancers/NNS
,/,
and/CC
insulators/NNS
,/,
in/IN
chromatin/NN
and/CC
chromatin-modifying/JJ
enzymes.Mutations/NNS
in/IN
tumor/NN
suppressors/NNS
and/or/CC
oncogenes/NNS
induce/VBP
a/DT
loss/NN
or/CC
gain/NN
of/IN
function/NN
,/,
respectively/RB
,/,
and/CC
abnormal/JJ
expression/NN
of/IN
these/DT
genes/NNS
are/VBP
likely/RB
to/TO
be/VB
linked/VBN
to/TO
cancer/NN
initiation/NN
./.
====================
Feinberg/NN
proposed/VBN
a/DT
hypothesis/NN
that/IN
epigenetic/JJ
alterations/NNS
can/MD
induce/VB
genetic/JJ
changes/NNS
and/CC
contribute/VBP
to/TO
tumor/NN
progression/NN
and/CC
also/RB
initiation/NN
[/(
7/CD
]/)
./.
====================
Epigenetic/JJ
changes/NNS
occur/VBP
without/IN
a/DT
change/NN
in/IN
the/DT
DNA/NN
sequence/NN
,/,
and/CC
they/PRP
can/MD
be/VB
induced/VBN
by/IN
various/JJ
factors/NNS
,/,
such/JJ
as/IN
chromatin/NN
structure/NN
,/,
including/VBG
DNA/NN
methylation/NN
,/,
histone/NN
variants/NNS
,/,
and/CC
modifications/NNS
;/:
nucleosome/JJ
remodeling/NN
;/:
and/CC
small/JJ
non-coding/JJ
regulatory/JJ
RNAs/NNS
(/(
Fig/NN
./.
====================
2/CD
)/)
[/(
8/CD
]/)
./.
====================
In/IN
addition/NN
to/TO
histone/NN
proteins/NNS
,/,
DNA/NN
is/VBZ
associated/VBN
with/IN
several/JJ
nonhistone/NN
chromosomal/JJ
proteins/NNS
,/,
including/VBG
high-mobility/JJ
group/NN
and/CC
heterochromatin/NN
protein/NN
1/CD
(/(
HP1/NN
)/)
,/,
which/WDT
can/MD
also/RB
play/VBP
an/DT
important/JJ
regulatory/JJ
role/NN
in/IN
DNA-dependent/JJ
processes/NNS
,/,
such/JJ
as/IN
transcription/NN
,/,
replication/NN
,/,
recombination/NN
,/,
and/CC
DNA/NN
repair/NN
,/,
in/IN
a/DT
similar/JJ
manner/NN
to/TO
histones/NNS
./.
====================
Histone/NN
modifications/NNS
and/CC
cancer/NN
====================
Nucleosomes/NNS
are/VBP
the/DT
basic/JJ
units/NNS
of/IN
chromatin/NN
that/DT
are/VBP
composed/VBN
of/IN
DNA/NN
wrapped/VBD
around/IN
8/CD
histone/NN
core/NN
proteins/NNS
[/(
9/CD
]/)
./.
====================
One/CD
of/IN
best/JJS
understood/VBN
epigenetic/JJ
mechanisms/NNS
is/VBZ
histone/NN
modification/NN
./.
====================
The/DT
histone/NN
N-terminal/JJ
tails/NNS
protrude/VBP
from/IN
nucleosome/JJ
cores/NNS
and/CC
thus/RB
are/VBP
subject/JJ
to/TO
numerous/JJ
modifications/NNS
,/,
such/JJ
as/IN
acetylation/NN
,/,
methylation/NN
,/,
phosphorylation/NN
,/,
ubiquitination/NN
,/,
ADP-ribosylation/NN
,/,
and/CC
citrullination/NN
,/,
creating/VBG
a/DT
massively/RB
complex/NN
bar/JJ
code/VBP
./.
====================
It/PRP
is/VBZ
thought/VBN
that/DT
activating/VBG
or/CC
repressive/JJ
complexes/NNS
are/VBP
recruited/VBN
to/TO
DNA/NN
and/CC
reshape/NN
chromatin/NN
into/IN
relaxed/JJ
or/CC
a/DT
tightly/RB
packed/VBN
structure/NN
,/,
based/VBN
on/IN
the/DT
histone/NN
code-instructions/NNS
through/IN
a/DT
combination/NN
of/IN
histone/NN
modifications/NNS
[/(
10/CD
]/)
./.
====================
Like/IN
a/DT
writer/JJ
,/,
histone-modifying/VBG
enzymes/NNS
write/IN
the/DT
histone/NN
code/VBP
via/IN
histone/NN
modifications/NNS
and/CC
mark/VBP
specific/JJ
sites/NNS
of/IN
the/DT
genome/NN
with/IN
histone/NN
modifications-for/IN
example/NN
,/,
active/JJ
promoter/NN
regions/NNS
that/IN
are/VBP
marked/JJ
with/IN
augmented/JJ
trimethylation/NN
in/IN
H3/NN
at/IN
lysine/NN
4/CD
(/(
H3K4me3/NNP
)/)
inactive/JJ
promoters/NNS
that/IN
are/VBP
marked/JJ
with/IN
augmented/JJ
trimethylated/VBN
H3/NN
at/IN
lysine/NN
27/CD
(/(
H3K27me3/NNP
)/)
or/CC
trimethylated/JJ
H3/NN
at/IN
lysine/NN
9/CD
(/(
H3K9me3/NNP
)/)
,/,
and/CC
enhancers/NNS
that/IN
are/VBP
marked/JJ
with/IN
monomethylated/JJ
H3/NN
at/IN
lysine/NN
4/CD
(/(
H3K4me1/NNP
)/)
and/or/CC
acetylated/VBN
H3/NN
at/IN
lysine/NN
27/CD
(/(
H3K27ac/NNP
)/)
[/(
11-13/CD
]/)
./.
====================
These/DT
histone/NN
modification/NN
patterns/NNS
are/VBP
regulated/VBN
by/IN
a/DT
variety/NN
of/IN
enzymes/NNS
,/,
including/VBG
histone/NN
acetyltransferases/NNS
and/CC
deacetylases/NNS
,/,
which/WDT
introduce/VBP
and/CC
remove/VB
acetyl/NN
groups/NNS
,/,
respectively/RB
./.
====================
Similarly/RB
,/,
histone/NN
methyltransferases/NNS
(/(
HMTs/NNS
)/)
and/CC
demethylases/VBZ
introduce/VBP
and/CC
remove/VBP
methyl/NN
groups/NNS
./.
====================
The/DT
combination/NN
of/IN
histone/NN
modifications/NNS
largely/RB
affects/VBZ
gene/NN
expression/NN
by/IN
the/DT
recruitment/NN
of/IN
transcriptional/JJ
regulatory/JJ
proteins/NNS
,/,
which/WDT
bind/VBP
to/TO
specific/JJ
modified/VBN
histone/NN
markings/NNS
./.
====================
Thus/RB
,/,
a/DT
combination/NN
of/IN
histone/NN
modifications/NNS
acts/VBZ
as/IN
a/DT
histone/NN
code-high-level/NN
information/NN
residing/VBG
above/IN
the/DT
genetic/JJ
code/VBP
,/,
which/WDT
is/VBZ
genetic/JJ
information/NN
stored/VBD
in/IN
the/DT
form/NN
of/IN
DNA/NN
./.
====================
Aberrant/JJ
patterns/NNS
of/IN
histone/NN
modification/NN
marks/VBZ
are/VBP
often/RB
found/VBN
in/IN
cancer/NN
./.
====================
Advances/NNS
in/IN
high-throughput/JJ
sequencing/NN
have/VBP
allowed/VBN
for/IN
genome-wide/NN
mapping/NN
of/IN
chromatin/NN
changes/NNS
that/WDT
occur/VBP
during/IN
tumor/NN
initiation/NN
and/CC
progression/NN
[/(
8/CD
]/)
./.
====================
A/DT
recent/JJ
report/NN
suggested/VBD
that/IN
cancer/NN
cells/NNS
often/RB
experience/VBP
losses/NNS
of/IN
histone/NN
acetylation/NN
and/CC
methylation/NN
,/,
occurring/VBG
predominantly/RB
at/IN
the/DT
acetylated/VBN
Lys16/NN
and/CC
trimethylated/VBD
Lys20/NN
residues/NNS
in/IN
histone/NN
H4/NN
./.
====================
These/DT
losses/NNS
are/VBP
also/RB
associated/VBN
with/IN
the/DT
hypomethylation/NN
of/IN
repetitive/JJ
DNA/NN
sequences/NNS
,/,
which/WDT
is/VBZ
a/DT
well-known/JJ
characteristic/JJ
of/IN
cancer/NN
cells/NNS
[/(
14/CD
]/)
./.
====================
DNA/NN
methylation/NN
and/CC
cancer/NN
====================
One/CD
of/IN
the/DT
best/JJS
studied/VBN
epigenetic/JJ
signals/NNS
is/VBZ
DNA/NN
methylation/NN
./.
====================
In/IN
contrast/NN
to/TO
a/DT
dazzling/JJ
variety/NN
of/IN
histone/NN
modifications/NNS
,/,
DNA/NN
methylation/NN
is/VBZ
a/DT
simple/JJ
covalent/JJ
chemical/JJ
modification/NN
,/,
resulting/VBG
in/IN
the/DT
attachment/NN
of/IN
a/DT
methyl/JJ
(/(
CH3/NN
)/)
group/NN
at/IN
the/DT
5/CD
'/``
carbon/NN
position/NN
of/IN
the/DT
cytosine/NN
ring/NN
./.
====================
When/WRB
methyl/NN
groups/NNS
are/VBP
attached/VBN
to/TO
the/DT
DNA/NN
in/IN
genes/NNS
,/,
transcription/NN
of/IN
these/DT
genes/NNS
is/VBZ
usually/RB
turned/JJ
off/IN
,/,
and/CC
then/RB
these/DT
genes/NNS
are/VBP
silenced/VBN
./.
====================
When/WRB
a/DT
cell/NN
divides/NNS
,/,
its/PRP$
DNA/NN
is/VBZ
copied/VBN
via/IN
replication/NN
and/CC
divided/VBN
equally/RB
into/IN
two/CD
daughter/NN
cells/NNS
during/IN
mitosis/NN
./.
====================
During/IN
this/DT
process/NN
,/,
the/DT
pattern/NN
of/IN
DNA/NN
methylation/NN
can/MD
also/RB
be/VB
copied/VBN
onto/IN
the/DT
new/JJ
daughter/NN
DNA/NN
,/,
allowing/VBG
the/DT
information/NN
that/IN
determines/VBZ
whether/IN
a/DT
gene/NN
is/VBZ
``/CD
on/IN
''/NN
or/CC
``/JJ
off/IN
''/NNP
to/TO
be/VB
inherited/VBN
to/TO
the/DT
two/CD
daughter/NN
cells/NNS
[/(
15/CD
]/)
./.
====================
DNA/NN
methylation/NN
in/IN
mammals/NNS
occurs/VBZ
mostly/RB
at/IN
CpG/NN
dinucleotides/NNS
,/,
and/CC
methylation/NN
of/IN
CpG/NN
islands/NNS
explains/VBZ
a/DT
stable/JJ
gene/NN
silencing/NN
mechanism/NN
[/(
15/CD
]/)
./.
====================
In/IN
normal/JJ
somatic/JJ
cells/NNS
,/,
most/JJS
(/(
over/IN
50/CD
%/NN
)/)
CpG/NN
islands/NNS
are/VBP
unmethylated/VBN
./.
====================
DNA/NN
methylation/NN
is/VBZ
important/JJ
for/IN
the/DT
regulation/NN
of/IN
non-CpG/NN
islands/VBZ
,/,
CpG/NN
island/NN
promoters/NNS
,/,
and/CC
repetitive/JJ
sequences/NNS
to/TO
maintain/VB
genome/NN
stability/NN
[/(
15/CD
,/,
16/CD
]/)
./.
====================
Furthermore/RB
,/,
DNA/NN
methylation/NN
plays/VBZ
important/JJ
roles/NNS
in/IN
X/NN
chromosome/NN
inactivation/NN
,/,
imprinting/VBG
,/,
embryonic/JJ
development/NN
,/,
silencing/VBG
of/IN
repetitive/JJ
elements/NNS
and/CC
germ/NN
cell-specific/JJ
genes/NNS
,/,
differentiation/NN
,/,
and/CC
maintenance/NN
of/IN
pluripotency/NN
[/(
16-18/CD
]/)
./.
====================
DNA/NN
methylation/NN
is/VBZ
controlled/VBN
by/IN
a/DT
family/NN
of/IN
DNA/NN
methyltransferases/NNS
(/(
DNMTs/NNS
)/)
that/WDT
catalyze/VBP
the/DT
transfer/NN
of/IN
methyl/JJ
groups/NNS
from/IN
S-adenosyl-L-methionine/NN
to/TO
the/DT
5/CD
'/``
position/NN
of/IN
cytosine/NN
bases/NNS
in/IN
the/DT
CpG/NN
dinucleotide/NN
./.
====================
Methyl-binding/VBG
domain/NN
(/(
MBD/NN
)/)
proteins/NNS
,/,
such/JJ
as/IN
MeCP2/NN
,/,
MBD1/NN
,/,
MBD2/NN
,/,
and/CC
MBD4/NN
,/,
bind/VBP
to/TO
methylated/JJ
CpG/NN
sites/NNS
and/CC
are/VBP
involved/VBN
in/IN
transcriptional/JJ
repression/NN
[/(
19/CD
]/)
./.
====================
In/IN
cancer/NN
,/,
hypomethylation/NN
usually/RB
occurs/VBZ
at/IN
repeated/VBN
DNA/NN
sequences/NNS
,/,
such/JJ
as/IN
long/JJ
interspersed/JJ
nuclear/JJ
elements/NNS
,/,
whereas/IN
hypermethylation/NN
predominantly/RB
involves/VBZ
CpG/NN
islands/NNS
[/(
20/CD
]/)
./.
====================
DNA/NN
hypermethylation/NN
has/VBZ
been/VBN
shown/VBN
to/TO
result/VB
in/IN
abnormal/JJ
silencing/NN
of/IN
several/JJ
tumor/NN
suppressor/NN
genes/NNS
in/IN
most/JJS
types/NNS
of/IN
cancer/NN
[/(
21/CD
]/)
./.
====================
Thus/RB
,/,
DNA/NN
methylation/NN
is/VBZ
grossly/RB
reduced/VBD
,/,
but/CC
DNA/NN
hypermethylation/NN
is/VBZ
specifically/RB
and/CC
locally/RB
augmented/VBD
at/IN
CpG/NN
islands/NNS
at/IN
tumor/NN
suppressor/NN
genes/NNS
(/(
Table/JJ
1/CD
)/)
;/:
yet/RB
,/,
its/PRP$
involvement/NN
and/CC
role/NN
in/IN
tumorigenesis/NN
remain/VBP
controversial/JJ
./.
====================
Yet/RB
,/,
experimental/JJ
progress/NN
has/VBZ
added/VBN
an/DT
emerging/VBG
epigenetic/JJ
aberration/NN
,/,
``/NNP
aberrant/JJ
DNA/NN
methylation/NN
,/,
''/NNP
to/TO
an/DT
established/JJ
cancer/NN
hallmark/NN
,/,
``/NNP
genomic/JJ
instability/NN
./.
''/CD
====================
DNA/NN
hypermethylation/NN
at/IN
tumor/NN
suppressors/NNS
or/CC
genes/NNS
having/VBG
tumor/NN
suppressive/JJ
functions/NNS
is/VBZ
more/RBR
frequent/JJ
than/IN
their/PRP$
mutations/NNS
in/IN
cancer/NN
cells/NNS
./.
====================
Hundreds/NNS
to/TO
thousands/DT
of/IN
genes/NNS
are/VBP
hypermethylated/VBN
in/IN
cancer/NN
cells/NNS
,/,
while/IN
only/RB
tens/NNS
of/IN
genes/NNS
are/VBP
mutated/VBN
./.
====================
Epigenetic/JJ
silencing/NN
via/IN
DNA/NN
methylation/NN
results/NNS
in/IN
gene/NN
inactivation/NN
and/CC
promotes/VBZ
carcinogenesis/NN
,/,
indicating/VBG
that/IN
DNA/NN
methylation/NN
impinges/VBZ
on/IN
carcinogenesis/NN
./.
====================
MicroRNA/NN
and/CC
cancer/NN
====================
MicroRNAs/NNS
(/(
miRNAs/NNS
)/)
constitute/VBP
a/DT
class/NN
of/IN
small/JJ
noncoding/JJ
RNAs/NNS
that/DT
have/VBP
epigenetic/JJ
functions/NNS
in/IN
posttranscriptional/JJ
regulation/NN
of/IN
gene/NN
expression/NN
via/IN
mRNA/NN
degradation/NN
or/CC
sequestering/VBG
and/CC
translational/JJ
repression/NN
and/CC
have/VBP
physiologically/RB
essential/JJ
roles/NNS
in/IN
most/JJS
cellular/JJ
processes/NNS
./.
====================
Therefore/RB
,/,
their/PRP$
dysfunction/NN
is/VBZ
implicated/VBN
in/IN
human/JJ
diseases/NNS
,/,
including/VBG
cancer/NN
,/,
as/IN
well/RB
as/IN
inherited/VBN
diseases/NNS
and/CC
developmental/JJ
defects/NNS
./.
====================
The/DT
human/JJ
genome/NN
may/MD
encode/VB
over/IN
1,400/CD
miRNAs/NNS
,/,
which/WDT
frequently/RB
target/NN
many/JJ
genes/NNS
related/JJ
to/TO
cancer/NN
development/NN
or/CC
prevention/NN
[/(
22/CD
]/)
./.
====================
In/IN
light/NN
of/IN
the/DT
linkage/NN
between/IN
miRNA/NN
and/CC
cancer/NN
,/,
they/PRP
have/VBP
been/VBN
categorized/VBN
into/IN
three/CD
groups/NNS
:/:
oncogenic/JJ
,/,
tumor-suppressive/JJ
,/,
or/CC
context-dependent/JJ
miRNAs/NNS
[/(
23/CD
]/)
./.
====================
In/IN
tumorigenesis/NN
,/,
the/DT
loss/NN
of/IN
tumor-suppressive/JJ
miRNAs/NNS
promotes/VBZ
the/DT
expression/NN
of/IN
target/NN
oncogenes/NNS
,/,
while/IN
increased/VBD
expression/NN
of/IN
oncogenic/JJ
miRNAs/NNS
can/MD
repress/VB
target/NN
tumor/NN
suppressor/NN
genes/NNS
[/(
23/CD
]/)
./.
====================
Mutations/NNS
in/IN
a/DT
miRNA/JJ
can/MD
disrupt/VB
its/PRP$
recognition/NN
of/IN
binding/VBG
targets/NNS
and/CC
further/RBR
result/NN
in/IN
oncogene/NN
activation/NN
and/or/CC
tumor/NN
suppressor/NN
repression/NN
./.
====================
Indeed/RB
,/,
oncogenic/JJ
miRNAs/NNS
,/,
such/JJ
as/IN
miR-155/JJ
,/,
miR-21/NN
,/,
and/CC
miR-17/NN
to/TO
-92/CD
,/,
whose/WP$
expression/NN
triggers/VBZ
cancer/NN
development/NN
,/,
appear/VBP
to/TO
be/VB
amplified/VBN
,/,
and/CC
tumor/NN
suppressive/JJ
miRNAs/NNS
,/,
such/JJ
as/IN
miR-146/RB
and/CC
miR-15/NN
to/TO
-16/CD
,/,
whose/WP$
loss/NN
triggers/VBZ
cancer/NN
development/NN
,/,
appear/VBP
to/TO
be/VB
downregulated/VBN
in/IN
cancers/NNS
[/(
23/CD
]/)
./.
====================
Moreover/RB
,/,
mutations/NNS
of/IN
miRNAs/NNS
,/,
including/VBG
miR-101/NN
and/CC
miR-29/NN
,/,
targeting/VBG
epigenetically/RB
modifying/VBG
enzymes/NNS
,/,
such/JJ
as/IN
EZH2/NN
[/(
24/CD
,/,
25/CD
]/)
and/CC
DNMT3/NN
[/(
26/CD
]/)
,/,
respectively/RB
,/,
are/VBP
often/RB
found/VBN
in/IN
human/JJ
cancers/NNS
./.
====================
Aberrant/JJ
expression/NN
or/CC
mutation/NN
of/IN
such/JJ
miRNAs/NNS
is/VBZ
likely/JJ
to/TO
further/RBR
reinforce/VBP
extensive/JJ
and/CC
heavy/JJ
epigenetic/JJ
alterations/NNS
[/(
23/CD
,/,
27/CD
]/)
and/CC
might/MD
have/VBP
effects/NNS
on/IN
histone/NN
or/CC
DNA/NN
methylation/NN
at/IN
promoters/NNS
of/IN
other/JJ
miRNAs/NNS
that/DT
target/NN
oncogenes/NNS
and/CC
tumor/NN
suppressors/NNS
./.
====================
Underexpression/NN
of/IN
miR-127/NN
,/,
which/WDT
targets/VBZ
BCL6/NN
,/,
is/VBZ
correlated/VBN
with/IN
abnormal/JJ
methylation/NN
at/IN
its/PRP$
promoter/NN
in/IN
cancer/NN
[/(
28/CD
]/)
./.
====================
In/IN
the/DT
course/NN
of/IN
remarkable/JJ
progress/VBP
in/IN
the/DT
study/NN
of/IN
cancer/NN
epigenetics/NNS
,/,
new/JJ
observations/NNS
linking/VBG
aberrant/JJ
miRNA/NN
expression/NN
and/CC
tumorigenesis/NN
imply/VBP
that/IN
miR-mimic/JJ
molecules/NNS
might/MD
serve/VB
as/IN
effective/JJ
therapeutics/NNS
by/IN
replacing/VBG
tumor/NN
suppressor/NN
miRs/NNS
or/CC
targeting/VBG
oncogenic/JJ
miRs/NNS
./.
====================
Many/JJ
types/NNS
of/IN
human/JJ
cancers/NNS
and/CC
disorders/diseases/VBZ
are/VBP
often/RB
induced/VBN
by/IN
misregulation/NN
of/IN
gene/NN
expression/NN
./.
====================
Mechasnims/NNS
for/IN
this/DT
misregulation/NN
involve/VBP
both/DT
genetic/JJ
mutations/NNS
(/(
genetic/JJ
instability/NN
)/)
and/CC
epigenetic/JJ
modifications/NNS
that/IN
disrupt/VBP
the/DT
function/NN
of/IN
genes/NNS
,/,
including/VBG
tumor/NN
suppressor/NN
and/CC
oncogenes/NNS
,/,
as/IN
well/RB
as/IN
other/JJ
genes/NNS
related/JJ
to/TO
cancer/NN
,/,
via/IN
altered/JJ
activity/NN
or/CC
expression/NN
of/IN
the/DT
products/NNS
of/IN
the/DT
genes/NNS
./.
====================
Given/IN
the/DT
importance/NN
of/IN
epigenetic/JJ
dysregulation/NN
in/IN
tumor/NN
initiation/NN
and/CC
development/NN
,/,
differentiating/VBG
causative/JJ
``/CD
drivers/VBZ
''/CD
(/(
causes/VBZ
)/)
and/CC
resulting/VBG
``/NN
passengers/NNS
''/CD
(/(
outcomes/NNS
)/)
is/VBZ
becoming/VBG
an/DT
important/JJ
priority/NN
for/IN
cancer/NN
biology/NN
as/IN
well/RB
as/IN
epigenetics/NNS
./.
====================
Driver/RB
genes/NNS
have/VBP
to/TO
be/VB
essential/JJ
for/IN
cancer/NN
causation/NN
,/,
whereas/IN
passenger/NN
genes/NNS
are/VBP
not/RB
necessary/JJ
[/(
29/CD
]/)
./.
====================
By/IN
the/DT
development/NN
and/CC
improvement/NN
of/IN
technology/NN
,/,
it/PRP
may/MD
eventually/RB
be/VB
possible/JJ
to/TO
accurately/RB
and/CC
minutely/RB
distinguish/VBP
epigenetic/JJ
aberrations/NNS
of/IN
driver/RB
genes/NNS
[/(
30/CD
,/,
31/CD
]/)
./.
====================
Many/JJ
current/JJ
clinical/JJ
investigations/NNS
and/CC
trials/NNS
of/IN
epigenetics-based/JJ
cancer/NN
therapy/NN
,/,
highlighting/VBG
the/DT
reciprocal/JJ
regulation/NN
of/IN
epigenetically/RB
modifying/VBG
enzymes/NNS
,/,
miRNAs/NNS
,/,
and/CC
genetic/JJ
defects/NNS
in/IN
cancer/NN
,/,
have/VBP
come/VBN
from/IN
scientific/JJ
discoveries/VBZ
of/IN
how/WRB
epigenetic/JJ
aberrations/NNS
in/IN
cancer/NN
manage/VBP
to/TO
play/VB
a/DT
key/JJ
role/NN
at/IN
every/RB
stage/NN
of/IN
tumorigenesis/NN
and/CC
have/VBP
such/JJ
a/DT
profound/JJ
impact/NN
on/IN
the/DT
underlying/VBG
mechanisms/NNS
of/IN
tumorigenesis/NN
./.
====================
Nevertheless/RB
,/,
cooperation/NN
between/IN
epigenetics/NNS
and/CC
genetics/NNS
in/IN
tumorigenesis/NN
(/(
Fig/NN
./.
====================
3/CD
)/)
is/VBZ
the/DT
subject/JJ
of/IN
debate/NN
./.
====================
The/DT
interconnection/NN
between/IN
these/DT
two/CD
processes/NNS
becomes/VBZ
increasingly/RB
apparent/JJ
,/,
in/IN
large/JJ
part/NN
because/IN
it/PRP
is/VBZ
realized/VBN
that/IN
mutations/NNS
of/IN
various/JJ
epigenetic/JJ
modifier/NN
genes/NNS
are/VBP
associated/VBN
with/IN
human/JJ
cancers/NNS
[/(
32/CD
]/)
./.
====================
The/DT
mutation/NN
of/IN
epigenetic/JJ
modifiers/NNS
presumably/RB
fosters/VBZ
profound/JJ
epigenetic/JJ
anomalies/NNS
in/IN
terms/NNS
of/IN
DNA/NN
methylation/NN
,/,
histone/NN
modifications/NNS
,/,
miRNA/JJ
,/,
and/CC
nucleosome/JJ
positioning/JJ
and/CC
occupancy/NN
,/,
which/WDT
expedites/VBZ
global/JJ
dysregulation/NN
of/IN
gene/NN
expression/NN
./.
====================
Underlying/VBG
this/DT
dysregulated/VBN
epigenome/NN
is/VBZ
genomic/JJ
instability/NN
,/,
which/WDT
generates/VBZ
mutations/NNS
in/IN
epigenetic/JJ
modifiers/NNS
that/DT
induce/VBP
abnormal/JJ
gene/NN
expression/NN
,/,
which/WDT
may/MD
predispose/VB
one/CD
to/TO
cancer/NN
[/(
32/CD
]/)
,/,
although/IN
this/DT
remains/VBZ
to/TO
be/VB
demonstrated/VBN
./.
====================
Insight/RB
into/IN
its/PRP$
underlying/VBG
mechanisms/NNS
helps/VBZ
establish/VBP
the/DT
epigenetic/JJ
involvement/NN
in/IN
tumorigenesis/NN
./.
====================
Because/IN
epigenetic/JJ
processes/NNS
involve/VBP
a/DT
number/NN
of/IN
overlapping/VBG
and/CC
interconnected/JJ
mechanisms/NNS
and/CC
pathways/NNS
,/,
it/PRP
is/VBZ
difficult/JJ
to/TO
definitely/RB
identify/VBP
the/DT
cellular/JJ
and/CC
molecular/JJ
identities/NNS
and/CC
the/DT
mechanism/NN
(/(
s/NNS
)/)
underlying/VBG
the/DT
epigenetic/JJ
outcomes/NNS
and/CC
phenotype/NN
./.
====================
Based/VBN
on/IN
studies/NNS
of/IN
cell/NN
lines/NNS
that/WDT
have/VBP
originated/VBN
from/IN
tumor/NN
tissues/NNS
and/CC
tissue/NN
samples/NNS
collected/JJ
from/IN
cancer/NN
patients/NNS
,/,
aberrant/JJ
epigenetic/JJ
marks/NNS
can/MD
result/VB
in/IN
inappropriate/JJ
expression/NN
of/IN
genes/NNS
that/WDT
are/VBP
associated/VBN
with/IN
cancer/NN
(/(
tumor/NN
suppressors/NNS
and/or/CC
oncogenes/NNS
)/)
./.
====================
It/PRP
is/VBZ
now/RB
generally/RB
accepted/VBN
that/IN
human/JJ
cancer/NN
cells/NNS
harbor/VBP
global/JJ
epigenetic/JJ
abnormalities/NNS
and/CC
that/IN
epigenetic/JJ
alterations/NNS
may/MD
be/VB
the/DT
key/JJ
to/TO
tumor/NN
initiation/NN
and/CC
development/NN
[/(
5/CD
,/,
6/CD
,/,
8/CD
]/)
./.
====================
The/DT
cancer/NN
epigenome/DT
is/VBZ
characterized/VBN
by/IN
substantial/JJ
changes/NNS
in/IN
various/JJ
epigenetic/JJ
regulatory/JJ
layers/NNS
;/:
herein/RB
,/,
we/PRP
introduce/VBP
some/DT
important/JJ
examples/NNS
of/IN
epigenetic/JJ
disruptions/NNS
that/DT
cause/VBP
mutations/NNS
of/IN
key/JJ
genes/NNS
and/or/CC
alterations/NNS
of/IN
signaling/VBG
pathways/NNS
in/IN
cancer/NN
development/NN
./.
====================
However/RB
,/,
this/DT
idea/NN
has/VBZ
now/RB
been/VBN
expanded/VBN
to/TO
be/VB
a/DT
scientific/JJ
norm/JJ
by/IN
consolidating/VBG
and/CC
incorporating/VBG
the/DT
altered/JJ
epigenetic/JJ
regulatory/JJ
mechanisms/NNS
that/WDT
are/VBP
common/JJ
and/CC
prevalent/JJ
in/IN
cancer/NN
[/(
5/CD
,/,
6/CD
]/)
./.
====================
Both/DT
genetics/NNS
and/CC
epigenetics/NNS
ultimately/RB
involve/VBP
abnormal/JJ
gene/NN
expression-i.e./FW
,/,
phenotype/NN
./.
====================
The/DT
expression/NN
level/NN
of/IN
a/DT
particular/JJ
gene/NN
is/VBZ
determined/VBN
by/IN
its/PRP$
context/NN
at/IN
the/DT
genetic/JJ
level/NN
,/,
which/WDT
consists/VBZ
of/IN
several/JJ
cis/NN
elements/NNS
,/,
including/VBG
promoters/NNS
,/,
regulatory/JJ
regions/NNS
,/,
enhancers/NNS
,/,
and/CC
insulators/NNS
,/,
each/DT
of/IN
which/WDT
recruits/VBZ
specific/JJ
transcriptional/JJ
proteins/NNS
for/IN
activation/NN
,/,
repression/NN
,/,
and/CC
constitutive/JJ
or/CC
facultative/JJ
transcription/NN
by/IN
various/JJ
mechanisms/NNS
./.
====================
In/IN
other/JJ
words/NNS
,/,
cis/NN
elements/NNS
can/MD
act/VB
as/IN
a/DT
primary/JJ
platform/NN
for/IN
recruiting/VBG
epigenome-modifying/VBG
enzymes/NNS
and/or/CC
chromatin/NN
remodeling/NN
factors/NNS
./.
====================
The/DT
modified/VBN
epigenome/NN
follows/VBZ
immediately/RB
and/CC
acts/VBZ
as/IN
a/DT
secondary/JJ
platform/NN
for/IN
transcriptional/JJ
effector/NN
machinery/NN
./.
====================
Finally/RB
,/,
transcription/NN
is/VBZ
turned/VBN
on/IN
or/CC
off/IN
,/,
and/CC
its/PRP$
level/NN
is/VBZ
determined/VBN
by/IN
the/DT
overall/JJ
epigenomic/JJ
context/NN
./.
====================
The/DT
genetic/JJ
road/NN
to/TO
cancer/NN
is/VBZ
relatively/RB
straightforward/JJ
:/:
mutation/NN
of/IN
tumor/NN
suppressors/NNS
and/or/CC
oncogenes/NNS
causes/VBZ
either/CC
a/DT
loss/NN
or/CC
gain/NN
of/IN
function/NN
and/CC
abnormal/JJ
expression-namely/RB
the/DT
very/RB
relationship/NN
between/IN
altered/JJ
genotypealtered/VBN
phenotype/NN
./.
====================
On/IN
the/DT
contrary/NN
,/,
there/EX
are/VBP
no/DT
genetic/JJ
changes/NNS
but/CC
a/DT
sick/JJ
phenotype/NN
in/IN
the/DT
epigenetic/JJ
road/JJ
to/TO
cancer/NN
./.
====================
The/DT
epigenetic/JJ
pathway/NN
to/TO
cancer/NN
is/VBZ
much/RB
more/RBR
complicated/VBN
and/CC
roundabout/RB
and/CC
is/VBZ
determined/VBN
by/IN
integrating/VBG
numerous/JJ
epigenetic/JJ
variations/NNS
,/,
including/VBG
DNA/NN
methylation/NN
,/,
histone/NN
variants/NNS
and/CC
modifications/NNS
,/,
and/CC
nucleosome/JJ
remodeling/NN
,/,
as/IN
well/RB
as/IN
small/JJ
non-coding/JJ
regulatory/JJ
RNAs/NNS
(/(
Fig/NN
./.
====================
2/CD
)/)
[/(
8/CD
]/)
./.
====================
During/IN
tumor/NN
initiation/NN
and/CC
progression/NN
,/,
the/DT
epigenome/JJ
undergoes/VBZ
multiple/JJ
alterations/NNS
,/,
including/VBG
a/DT
genome-wide/JJ
loss/NN
of/IN
DNA/NN
methylation/NN
(/(
hypomethylation/NN
)/)
,/,
frequent/JJ
increases/VBZ
in/IN
promoter/NN
methylation/NN
of/IN
CpG/NN
islands/VBZ
,/,
and/CC
aberrant/JJ
changes/NNS
in/IN
nucleosome/JJ
occupancy/NN
and/CC
histone/NN
modification/NN
profile/NN
,/,
and/CC
these/DT
epigenetic/JJ
aberrations/NNS
drive/VBP
tumor/NN
cell/NN
heterogeneity/NN
,/,
as/IN
well/RB
as/IN
tumorigenesis/NN
./.
====================
Epigenetic/JJ
aberration/NN
is/VBZ
a/DT
major/JJ
feature/NN
of/IN
cancer/NN
,/,
but/CC
its/PRP$
etiological/JJ
role/NN
in/IN
tumor/NN
development/NN
remains/VBZ
controversial/JJ
./.
====================
This/DT
contrasts/VBZ
with/IN
genomic/JJ
instability/NN
,/,
which/WDT
is/VBZ
known/VBN
to/TO
produce/VB
cancer-causing/VBG
mutations/NNS
./.
====================
Recent/JJ
evidence/NN
demonstrates/VBZ
that/IN
a/DT
dysregulated/VBN
epigenome/NN
can/MD
promote/VB
tumorigenesis/NN
via/IN
altered/JJ
gene/NN
expression/NN
;/:
however/RB
,/,
the/DT
question/NN
of/IN
whether/IN
a/DT
dysregulated/VBN
epigenome/NN
can/MD
predispose/VB
one/CD
to/TO
DNA/NN
damage/NN
and/CC
generate/VBP
genomic/JJ
instability/NN
remains/VBZ
clearly/RB
unaddressed/JJ
./.
====================
Only/RB
few/JJ
possible/JJ
mechanisms/NNS
have/VBP
been/VBN
proposed/VBN
;/:
one/CD
possible/JJ
mechanism/NN
by/IN
which/WDT
chromosome/NN
segregation/NN
errors/NNS
promote/VBP
tumorigenesis/NN
is/VBZ
by/IN
inhibiting/VBG
chromosome/NN
condensation/NN
for/IN
mitotic/JJ
entry/NN
or/CC
destabilizing/VBG
heterochromatin/NN
at/IN
centromeres/NNS
,/,
which/WDT
facilitates/VBZ
chromosomal/JJ
misalignment/JJ
and/CC
accelerates/VBZ
the/DT
formation/NN
of/IN
unattached/JJ
chromosomes/NNS
or/CC
malfunctioning/VBG
spindles/NNS
./.
====================
A/DT
second/JJ
mechanism/NN
is/VBZ
chromosomal/JJ
breakage/NN
and/CC
non-homologous/JJ
end-joining/JJ
,/,
which/WDT
result/VBP
in/IN
chromosomal/JJ
rearrangement/NN
and/CC
extensive/JJ
structural/JJ
alterations/NNS
in/IN
chromosomes/NNS
./.
====================
Third/RB
,/,
a/DT
dysregulated/VBN
epigenome/NN
at/IN
telomeres/NNS
promotes/VBZ
its/PRP$
elongation/NN
or/CC
chromosomal/JJ
rearrangement/NN
./.
====================
Intriguingly/RB
,/,
histone/NN
deacetylase/NN
inhibitors/NNS
or/CC
knockdown/knockout/JJ
of/IN
epigenome/JJ
modifiers/NNS
can/MD
induce/VB
DNA/NN
damage/NN
,/,
but/CC
whether/IN
this/DT
DNA/NN
damage/NN
can/MD
indeed/RB
predispose/VBP
one/CD
to/TO
cancer/NN
remains/VBZ
unestablished/JJ
./.
====================
Heterochromatin/NN
protein/NN
1/CD
====================
HP1/NN
was/VBD
originally/RB
identified/VBN
in/IN
Drosophila/FW
,/,
functioning/VBG
in/IN
heterochromatin-mediated/JJ
gene/NN
silencing/NN
./.
====================
Three/CD
different/JJ
paralogs/NNS
of/IN
HP1/NN
are/VBP
found/VBN
in/IN
Drosophila/FW
melanogaster/NN
:/:
HP1a/NN
,/,
HP1b/NN
,/,
and/CC
HP1c/NN
./.
====================
Subsequently/RB
,/,
orthologs/NNS
of/IN
HP1/NN
were/VBD
also/RB
discovered/VBD
in/IN
Schizosaccharomyces/NNS
pombe/VBP
(/(
Swi6/NN
)/)
,/,
xenopus/FW
(/(
Xhp1α/NNP
and/CC
Xhp1γ/JJ
)/)
,/,
chicken/NN
(/(
CHCB1/NN
,/,
CHCB2/NN
,/,
and/CC
CHCB3/NN
)/)
,/,
and/CC
mammals/NNS
(/(
HP1α/NNP
,/,
HP1β/NNP
,/,
and/CC
HP1γ/NN
)/)
(/(
Fig/NN
./.
====================
4/CD
)/)
[/(
33/CD
,/,
34/CD
]/)
./.
====================
HP1/NN
binds/VBZ
directly/RB
to/TO
the/DT
methylated/JJ
K9/NN
residue/NN
of/IN
histone/NN
H3/NN
(/(
H3K9me/NN
)/)
,/,
a/DT
surrogate/NN
marker/NN
for/IN
transcriptionally/RB
repressive/JJ
heterochromatin/NN
,/,
and/CC
is/VBZ
critical/JJ
for/IN
its/PRP$
maintenance/NN
[/(
35-37/CD
]/)
./.
====================
Therefore/RB
,/,
its/PRP$
canonical/JJ
functions/NNS
include/VBP
maintaining/VBG
heterochromatin/NN
integrity/NN
as/IN
a/DT
fundamental/JJ
unit/NN
of/IN
heterochromatin/NN
,/,
silencing/VBG
by/IN
heterochromatin/NN
formation/NN
,/,
and/CC
gene/NN
repression/NN
by/IN
heterochromatization/NN
of/IN
euchromatin/JJ
./.
====================
HP1/NN
proteins/NNS
are/VBP
characterized/VBN
by/IN
two/CD
conserved/VBN
domains/NNS
:/:
the/DT
chromodomain/NN
(/(
CD/NN
)/)
in/IN
its/PRP$
N-terminus/NN
and/CC
the/DT
chromo/NN
shadow/VBP
domain/NN
(/(
CSD/NN
)/)
in/IN
the/DT
C-terminus/NN
(/(
Fig/NN
./.
====================
4/CD
)/)
./.
====================
The/DT
CD/NN
has/VBZ
been/VBN
shown/VBN
to/TO
directly/RB
bind/VBP
H3K9me/NN
,/,
while/IN
the/DT
CSD/NN
is/VBZ
implicated/VBN
in/IN
interacting/VBG
with/IN
a/DT
partner/NN
protein/NN
and/CC
its/PRP$
homo-/JJ
and/CC
hetero-dimerization/NN
./.
====================
Two/CD
CD/NN
and/CC
CSD/NN
domains/NNS
are/VBP
separated/VBN
by/IN
a/DT
hinge/NN
domain/NN
that/WDT
is/VBZ
involved/VBN
in/IN
DNA/NN
and/CC
RNA/NN
binding/NN
(/(
Figs/NNS
./.
====================
4/CD
and/CC
5/CD
)/)
[/(
38/CD
,/,
39/CD
]/)
./.
====================
HP1/NN
interacts/VBZ
with/IN
numerous/JJ
epigenomic/JJ
modifiers/NNS
with/IN
different/JJ
cellular/JJ
functions/NNS
in/IN
different/JJ
organisms/NNS
(/(
Fig/NN
./.
====================
5/CD
)/)
./.
====================
Some/DT
of/IN
these/DT
HP1-interacting/JJ
partners/NNS
are/VBP
histone/NN
methyltransferse/JJ
,/,
DNMT/NN
,/,
and/CC
methyl/NN
CpG-binding/NN
protein/NN
MeCP2/NN
(/(
Fig/NN
./.
====================
5/CD
)/)
,/,
supporting/VBG
its/PRP$
role/NN
in/IN
epigenomic/JJ
modification/NN
./.
====================
HP1/NN
and/CC
chromatin/NN
structure/NN
====================
HP1/NN
proteins/NNS
are/VBP
mostly/RB
enriched/VBN
at/IN
heterochromatin/NN
centromeres/NNS
and/CC
pericentromeric/JJ
regions/NNS
,/,
telomeres/NNS
and/CC
subtelomeric/JJ
regions/NNS
,/,
and/CC
transcriptionally/RB
repressive/JJ
genes/NNS
./.
====================
However/RB
,/,
HP1/NN
is/VBZ
also/RB
found/VBD
at/IN
euchromatic/JJ
sites/NNS
[/(
40/CD
,/,
41/CD
]/)
,/,
though/IN
whether/IN
euchromatic/JJ
HP1/NN
has/VBZ
a/DT
disparate/JJ
function/NN
and/CC
which/WDT
HP1/NN
paralog/NN
is/VBZ
located/JJ
at/IN
euchromatin/NN
remain/VBP
unclarified/JJ
./.
====================
A/DT
structure-based/JJ
study/NN
revealed/VBD
that/IN
a/DT
hydrophobic/JJ
pocket/NN
of/IN
the/DT
HP1/NN
CD/NN
interacts/VBZ
with/IN
histone/NN
H3K9me/NN
[/(
42/CD
]/)
./.
====================
This/DT
epigenetic/JJ
mark/VBP
is/VBZ
generated/VBN
by/IN
a/DT
conserved/VBN
family/NN
of/IN
HMTs/NNS
,/,
named/VBD
after/IN
the/DT
Drosophila/NN
member/NN
SU/NN
(/(
VAR/NN
)/)
3-9/CD
,/,
discovered/VBN
as/IN
a/DT
suppressor/NN
factor/NN
involved/VBN
in/IN
position-effect/JJ
variegation/NN
[/(
43/CD
,/,
44/CD
]/)
./.
====================
Both/DT
HP1/NN
and/CC
SU/NN
(/(
VAR/NN
)/)
3-9/CD
function/NN
in/IN
heterochromatin/NN
structure/NN
formation/NN
./.
====================
Loss/NN
of/IN
SU/NN
(/(
VAR/NN
)/)
3-9/CD
results/NNS
in/IN
displacement/JJ
of/IN
HP1/NN
from/IN
heterochromatic/JJ
regions/NNS
and/CC
alteration/NN
in/IN
gene/NN
repression/NN
[/(
45/CD
]/)
./.
====================
Mechanisms/NNS
by/IN
which/WDT
HP1/NN
localizes/VBZ
to/TO
euchromatin/JJ
sites/NNS
appear/VBP
to/TO
involve/VB
more/RBR
than/IN
the/DT
recognition/NN
of/IN
H3K9me/NN
,/,
which/WDT
is/VBZ
poorly/RB
understood/VBN
./.
====================
An/DT
alternative/JJ
mechanism/NN
of/IN
localization/NN
might/MD
be/VB
mediated/VBN
via/IN
interactions/NNS
between/IN
its/PRP$
CSD/NN
and/CC
other/JJ
factors/NNS
./.
====================
HP1/NN
CSD/NN
homodimerizes/VBZ
through/IN
an/DT
alpha-helical/JJ
region/NN
and/CC
generates/VBZ
a/DT
platform/JJ
that/DT
can/MD
interact/VB
with/IN
the/DT
PxVxL/NN
motif/NN
in/IN
its/PRP$
interacting/VBG
partner/NN
proteins/NNS
,/,
such/JJ
as/IN
DNMT1/3/NN
,/,
SU/NN
(/(
VAR/NN
)/)
3-9/CD
,/,
and/CC
the/DT
p150/NN
subunit/NN
of/IN
CAF-1/NN
(/(
Fig/NN
./.
====================
5/CD
)/)
[/(
46/CD
]/)
./.
====================
A/DT
second/JJ
alternative/JJ
mechanism/NN
of/IN
localization/NN
on/IN
chromatin/NN
involves/VBZ
interactions/NNS
with/IN
RNA/NN
through/IN
a/DT
hinge/NN
domain/NN
,/,
such/JJ
that/IN
association/NN
of/IN
HP1/NN
with/IN
specific/JJ
loci/NNS
in/IN
Drosophila/FW
and/CC
centric/JJ
regions/NNS
in/IN
mouse/NN
makes/VBZ
them/PRP
susceptible/JJ
to/TO
RNase/NN
treatment/NN
[/(
39/CD
,/,
47/CD
]/)
./.
====================
For/IN
example/NN
,/,
it/PRP
has/VBZ
been/VBN
demonstrated/VBN
that/IN
an/DT
HP1/NN
subcode/NN
with/IN
sumoylation/NN
plays/VBZ
a/DT
role/NN
in/IN
heterochromatin/NN
architecture/NN
,/,
via/IN
its/PRP$
association/NN
with/IN
microsatellite/NN
RNAs/NNS
[/(
48/CD
]/)
./.
====================
A/DT
third/JJ
mechanism/NN
for/IN
chromatin/NN
localization/NN
is/VBZ
found/VBN
at/IN
the/DT
distal/JJ
ends/NNS
of/IN
Drosophila/NN
telomeres/NNS
,/,
where/WRB
HP1/NN
is/VBZ
thought/VBN
to/TO
bind/VB
DNA/NN
directly/RB
[/(
49/CD
]/)
./.
====================
However/RB
,/,
in/IN
mammals/NNS
,/,
localization/NN
of/IN
HP1/NN
proteins/NNS
to/TO
telomeric/JJ
regions/NNS
occurs/VBZ
via/IN
H3K9/NN
association/NN
[/(
50-53/CD
]/)
./.
====================
Together/RB
,/,
HP1/NN
localizes/VBZ
to/TO
chromatin/NN
using/VBG
both/CC
genetic/JJ
(/(
DNA/NN
or/CC
RNA/NN
sequence/NN
)/)
and/CC
epigenetic/JJ
(/(
histone/NN
modification/NN
)/)
information/NN
./.
====================
HP1/NN
subcode/NN
:/:
above/JJ
the/DT
histone/NN
code/VBP
====================
Recently/RB
,/,
the/DT
``/NN
HP1/NN
subcode/VBP
''/NNP
hypothesis/NN
is/VBZ
emerging/VBG
in/IN
addition/NN
to/TO
the/DT
genetic/JJ
code/VBP
and/CC
histone/NN
code/VBP
:/:
a/DT
hypothesis/NN
that/IN
the/DT
transcription/NN
of/IN
genetic/JJ
information/NN
encoded/VBN
in/IN
DNA-i.e./FW
,/,
genetic/JJ
code-is/NN
regulated/VBN
in/IN
part/NN
by/IN
histone/NN
variants/NNS
,/,
modifications/NNS
,/,
and/CC
nucleosome/JJ
occupancy/NN
./.
====================
The/DT
histone/NN
code/VBP
hypothesis/NN
states/NNS
that/DT
the/DT
type/NN
and/CC
combination/NN
of/IN
histone/NN
modifications/NNS
are/VBP
interpreted/VBN
by/IN
the/DT
cell/NN
as/IN
instructions/NNS
for/IN
organizing/VBG
gene/NN
expression/NN
and/CC
constitutes/VBZ
the/DT
most/JJS
advanced/JJ
conceptual/JJ
framework/NN
for/IN
deciphering/VBG
the/DT
genetic/JJ
information/NN
cascades/NNS
that/IN
regulate/VBP
gene/NN
expression/NN
./.
====================
Further/RB
,/,
a/DT
combination/NN
of/IN
HP1/NN
paralogs/NNS
and/CC
modifications/NNS
may/MD
be/VB
defined/VBN
as/IN
a/DT
second/JJ
regulatory/JJ
layer/NN
of/IN
the/DT
code-that/NN
is/VBZ
,/,
a/DT
subcode-involved/JJ
in/IN
transcription/NN
,/,
especially/RB
gene/NN
silencing/NN
,/,
within/IN
the/DT
general/JJ
context/NN
of/IN
the/DT
histone/NN
code/VBP
./.
====================
The/DT
HP1/NN
subcode/VBP
can/MD
be/VB
secondary-level/JJ
information/NN
residing/VBG
above/IN
the/DT
genetic/JJ
and/CC
histone/NN
codes/VBZ
and/CC
regulate/VBP
HP1/NN
interactions/NNS
with/IN
other/JJ
key/JJ
proteins/NNS
,/,
further/RB
modulating/VBG
gene/NN
silencing/NN
and/CC
possibly/RB
replication/NN
,/,
recombination/NN
,/,
and/CC
DNA/NN
repair/NN
./.
====================
In/IN
this/DT
review/NN
,/,
we/PRP
will/MD
discuss/VB
the/DT
interplay/NN
between/IN
genetics/NNS
and/CC
epigenetics/NNS
in/IN
cancer/NN
through/IN
HP1/NN
./.
====================
Pleiotropic/JJ
functions/NNS
of/IN
HP1/NN
====================
Besides/RB
heterochromatin/NN
formation/NN
and/CC
the/DT
maintenance/NN
functions/NNS
of/IN
HP1/NN
,/,
this/DT
protein/NN
also/RB
recruits/VBZ
the/DT
cohesin/NN
complex/NN
to/TO
pericentromeric/JJ
heterochromatin/NN
for/IN
centromeric/JJ
sister/NN
chromatid/NN
cohesion/NN
./.
====================
Recent/JJ
studies/NNS
have/VBP
shown/VBN
that/IN
HP1/NN
does/VBZ
not/RB
always/RB
act/VBP
in/IN
the/DT
context/NN
of/IN
heterochromatin/NN
and/CC
functions/NNS
in/IN
gene/NN
activation/NN
and/CC
telomere/VBP
maintenance/NN
[/(
38/CD
]/)
./.
====================
Furthermore/RB
,/,
HP1/NN
interacts/VBZ
with/IN
many/JJ
different/JJ
proteins/NNS
,/,
including/VBG
transcription/NN
factors/NNS
,/,
chromatin/NN
regulators/NNS
,/,
and/CC
DNA/NN
replication/NN
and/CC
repair/NN
factors/NNS
,/,
as/IN
well/RB
as/IN
components/NNS
of/IN
the/DT
nuclear/JJ
envelope/NN
[/(
54/CD
]/)
,/,
and/CC
functions/NNS
via/IN
collaboration/JJ
with/IN
its/PRP$
interacting/VBG
proteins/NNS
in/IN
diverse/JJ
cellular/JJ
processes/NNS
,/,
including/VBG
mitosis/NN
progression/NN
[/(
55/CD
,/,
56/CD
]/)
,/,
DNA/NN
damage/NN
repair/NN
[/(
57-59/CD
]/)
,/,
transcription/NN
[/(
60-62/CD
]/)
,/,
and/CC
chromatin/NN
remodeling/NN
(/(
Figs/NNS
./.
====================
4/CD
and/CC
5/CD
)/)
[/(
63/CD
,/,
64/CD
]/)
./.
====================
HP1-mediated/JJ
transcriptional/JJ
regulation/NN
in/IN
response/NN
to/TO
DDR/NN
====================
Recently/RB
,/,
we/PRP
proposed/VBD
a/DT
mechanism/NN
in/IN
which/WDT
HP1/NN
could/MD
recover/RB
transcription/NN
in/IN
response/NN
to/TO
DNA/NN
damage/NN
signals/NNS
[/(
60/CD
]/)
./.
====================
HP1/NN
accumulates/VBZ
at/IN
the/DT
promoter/NN
before/IN
DNA/NN
damage/NN
,/,
but/CC
BRCA1/NN
is/VBZ
recruited/VBN
to/TO
the/DT
promoter/NN
after/IN
the/DT
damage/NN
while/IN
promoter-resident/JJ
HP1/NN
is/VBZ
disassembled/VBN
./.
====================
Importantly/RB
,/,
HP1/NN
assembly/NN
is/VBZ
recovered/VBN
post/RB
release/NN
from/IN
the/DT
damage/NN
in/IN
a/DT
BRCA1-HP1/NN
interaction-dependent/JJ
manner/NN
and/CC
simultaneously/RB
targets/NNS
SUV39H1/NN
to/TO
chromatin/NN
./.
====================
HP1/SUV39H1/NN
restoration/NN
at/IN
the/DT
promoter/NN
results/VBZ
in/IN
BRCA1/NN
disassembly/RB
and/CC
histone/NN
methylation/NN
./.
====================
In/IN
the/DT
aftermath/IN
,/,
transcriptional/JJ
repression/NN
resumes/VBZ
./.
====================
This/DT
report/NN
provides/VBZ
a/DT
partial/JJ
explanation/NN
for/IN
the/DT
targeting/VBG
of/IN
HP1/NN
to/TO
a/DT
variety/NN
of/IN
chromatin/NN
structures/NNS
and/CC
its/PRP$
functions/NNS
in/IN
constructing/VBG
de/FW
novo/FW
heterochromatin/NN
from/IN
euchromatin/JJ
or/CC
facultative/JJ
heterochromatin/NN
,/,
in/IN
addition/NN
to/TO
maintaining/VBG
previously/RB
existing/VBG
heterochromatin/NN
./.
====================
In/IN
addition/NN
,/,
a/DT
role/NN
in/IN
the/DT
DDR/NN
for/IN
HP1/NN
,/,
previously/RB
implicated/VBN
in/IN
heterochromatin/NN
and/CC
silencing/NN
,/,
reveals/VBZ
new/JJ
connections/NNS
between/IN
tumor-suppressive/JJ
processes/NNS
that/WDT
maintain/VBP
genome/NN
integrity/NN
./.
====================
HP1/NN
depletion/NN
activates/VBZ
DDRs/NNS
====================
Recent/JJ
studies/NNS
have/VBP
revealed/VBN
the/DT
possible/JJ
link/NN
of/IN
HP1/NN
proteins/NNS
to/TO
the/DT
DDR/NN
[/(
59/CD
,/,
65/CD
,/,
66/CD
]/)
./.
====================
However/RB
,/,
the/DT
spatial/JJ
and/CC
temporal/JJ
regulation/NN
of/IN
the/DT
association/NN
and/CC
dissociation/NN
of/IN
HP1/NN
with/IN
chromatin/NN
in/IN
response/NN
to/TO
DNA/NN
damage/NN
remains/VBZ
unclear/JJ
and/CC
controversial/JJ
./.
====================
A/DT
couple/JJ
of/IN
studies/NNS
have/VBP
reported/VBN
that/IN
DNA/NN
damage/NN
induces/VBZ
the/DT
transient/JJ
dissociation/NN
of/IN
inhibitory/JJ
HP1/NN
proteins/NNS
from/IN
DNA/NN
damage/NN
sites/NNS
in/IN
order/NN
to/TO
help/VB
DNA/NN
repair/NN
proteins/complexes/NNS
gain/NN
access/VBP
to/TO
chromatin/NN
[/(
65/CD
,/,
66/CD
]/)
./.
====================
In/IN
contrast/NN
,/,
another/DT
study/NN
has/VBZ
indicated/VBN
that/IN
HP1/NN
is/VBZ
recruited/VBN
and/CC
associates/VBZ
at/IN
DNA/NN
damage/NN
sites/NNS
,/,
such/JJ
as/IN
UV-induced/JJ
DNA/NN
lesions/NNS
and/CC
chromosomal/JJ
breaks/NNS
upon/IN
DNA/NN
damage/NN
,/,
which/WDT
helps/VBZ
the/DT
DDR/NN
via/IN
its/PRP$
dynamic/JJ
dissociation/NN
and/CC
association/NN
with/IN
DNA/NN
damage/NN
sites/NNS
[/(
59/CD
]/)
./.
====================
Recently/RB
,/,
Lee/NNP
and/CC
colleagues/NNS
[/(
67/CD
]/)
have/VBP
shown/VBN
that/IN
HP1/NN
promotes/VBZ
homologous/JJ
recombination/NN
repair/NN
via/IN
recruitment/NN
of/IN
BRCA1/NN
to/TO
damaged/VBN
chromatin/NN
./.
====================
Together/RB
,/,
chromatin/NN
protein/NN
HP1/NN
plays/VBZ
some/DT
unelucidated/JJ
roles/NNS
in/IN
keeping/VBG
genomic/JJ
as/IN
well/RB
as/IN
epigenomic/JJ
integrity/NN
./.
====================
Whether/IN
and/CC
how/WRB
HP1/NN
is/VBZ
related/JJ
to/TO
cancer/NN
====================
An/DT
aberrant/JJ
epigenome/NN
in/IN
cancer/NN
cells/NNS
results/VBZ
from/IN
an/DT
altered/JJ
chromatin/NN
structure/NN
resulting/VBG
from/IN
alterations/NNS
in/IN
chromatin-modifying/JJ
enzymes/NNS
and/or/CC
chromatin/NN
proteins/NNS
./.
====================
Examples/NNS
of/IN
HP1γ-interacting/JJ
proteins/NNS
are/VBP
the/DT
histone/NN
proteins/NNS
,/,
epigenetic/JJ
modifiers/NNS
,/,
transcription/NN
factor/NN
family/NN
,/,
DNA/NN
repair/NN
factors/NNS
,/,
and/CC
replication/NN
proteins/NNS
(/(
Fig/NN
./.
====================
5/CD
)/)
[/(
48/CD
,/,
54-57/CD
,/,
60/CD
,/,
62/CD
,/,
63/CD
,/,
67-80/CD
]/)
./.
====================
The/DT
diversity/NN
of/IN
HP1γ-associated/JJ
proteins/NNS
has/VBZ
increased/VBN
with/IN
the/DT
recent/JJ
discovery/NN
that/DT
HP1γ/NN
interacts/VBZ
with/IN
BRCA1/NN
,/,
a/DT
tumor/NN
suppressor/NN
that/DT
guards/VBZ
the/DT
genome/NN
./.
====================
In/IN
addition/NN
,/,
HP1γ/NNP
is/VBZ
involved/VBN
in/IN
the/DT
recovery/NN
of/IN
BRCA1-mediated/JJ
transcription/NN
post-DDR/NN
./.
====================
There/EX
is/VBZ
no/DT
direct/JJ
evidence/NN
that/IN
HP1γ/NN
is/VBZ
a/DT
component/NN
of/IN
BRCA1-mediated/JJ
tumor/NN
suppression/NN
./.
====================
However/RB
,/,
a/DT
couple/JJ
of/IN
tantalizing/VBG
observations/NNS
support/VBP
this/DT
possibility/NN
:/:
HP1γ/JJ
expression/NN
is/VBZ
elevated/JJ
in/IN
prostate/NN
cancer/NN
[/(
81/CD
]/)
,/,
and/CC
in/IN
addition/NN
,/,
depletion/NN
of/IN
HP1/NN
paralogs/NNS
activates/VBZ
the/DT
formation/NN
of/IN
DNA/NN
damage/NN
repair/NN
foci/NNS
./.
====================
HP1/NN
paralogsare/NN
recruited/VBN
to/TO
repair/NN
foci/NNS
and/CC
promote/VBP
DNA/NN
repair/NN
,/,
following/VBG
DNA/NN
damage/NN
./.
====================
This/DT
raises/VBZ
the/DT
question/NN
of/IN
whether/IN
increased/VBD
or/CC
decreased/VBD
HP1γ/NN
can/MD
foster/VB
or/CC
suppress/VB
tumor/NN
initiation/NN
and/CC
development/NN
./.
====================
In/IN
light/NN
of/IN
the/DT
HP1γ-BRCA1/NN
association/NN
,/,
it/PRP
would/MD
be/VB
intriguing/JJ
to/TO
test/VB
whether/IN
the/DT
genes/NNS
encoding/VBG
the/DT
HP1/NN
family/NN
are/VBP
also/RB
overexpressed/VBN
in/IN
breast/NN
cancers/NNS
./.
====================
It/PRP
would/MD
also/RB
be/VB
interesting/JJ
to/TO
test/VB
whether/IN
the/DT
HP1/NN
family/NN
impinges/VBZ
on/IN
genomic/JJ
stability/NN
./.
====================
On/IN
the/DT
road/JJ
to/TO
cancer/NN
:/:
genomic/JJ
instability/NN
./.
====================
Failure/NN
of/IN
DNA/NN
damage/NN
responses/NNS
that/DT
conduct/VBP
surveillance/NN
and/CC
checkpoints/NNS
to/TO
guard/JJ
genome/NN
causes/VBZ
genomic/JJ
instability/NN
,/,
the/DT
most/JJS
common/JJ
characteristic/JJ
of/IN
human/JJ
cancers/NNS
./.
====================
It/PRP
has/VBZ
therefore/RB
been/VBN
proposed/VBN
that/IN
genomic/JJ
instability/NN
contributes/VBZ
to/TO
and/CC
drives/VBZ
tumor/NN
initiation/NN
and/CC
development/NN
./.
====================
Defects/NNS
in/IN
the/DT
DNA/NN
damage/NN
responses/NNS
generate/VBP
genomic/JJ
instability/NN
and/CC
facilitate/VBP
tumorigenesis/NN
./.
====================
Epigenetic/JJ
mechanisms/NNS
./.
====================
Variations/NNS
in/IN
chromatin/NN
structure/NN
but/CC
not/RB
DNA/NN
sequences/NNS
modulate/VBP
the/DT
use/NN
of/IN
the/DT
genome/NN
by/IN
1/CD
)/)
DNA/NN
methylation/NN
,/,
2/CD
)/)
histone/NN
modifications/NNS
(/(
methylation/NN
,/,
phosphorylation/NN
,/,
and/CC
acetylation/NN
)/)
,/,
3/CD
)/)
histone/NN
variant/JJ
composition/NN
(/(
dark/NN
)/)
,/,
4/CD
)/)
chromatin/NN
remodeling/NN
(/(
sparse/JJ
or/CC
dense/JJ
nucleosome/JJ
occupancy/NN
)/)
,/,
and/CC
noncoding/JJ
RNAs/NNS
./.
====================
Epigenetic/JJ
silencing/NN
is/VBZ
more/RBR
frequent/JJ
that/DT
mutations/NNS
in/IN
cancer/NN
cells/NNS
./.
====================
In/IN
cancer/NN
cells/NNS
,/,
hundreds/VBZ
to/TO
thousands/DT
of/IN
genes/NNS
are/VBP
hypermethylated/VBN
(/(
DNA/NN
methylation/NN
)/)
,/,
histone/NN
codes/VBZ
at/IN
more/RBR
than/IN
thousands/DT
of/IN
genes/NNS
are/VBP
aberrantly/RB
modified/VBN
via/IN
histone/NN
modifications/NNS
or/CC
histone/NN
variant/JJ
compositions/NNS
,/,
and/CC
miRNA/JJ
expression/NN
is/VBZ
dysregulated/VBN
,/,
while/IN
tens/NNS
of/IN
genes/NNS
are/VBP
affected/VBN
by/IN
mutations/NNS
./.
====================
Both/DT
epigenetic/JJ
silencing/NN
and/CC
inactivating/VBG
mutations/NNS
or/CC
deletions/NNS
result/NN
in/IN
gene/NN
inactivation/NN
./.
====================
(/(
A/NN
)/)
Heterochromatin/NN
protein/NN
1/CD
(/(
HP1/NN
)/)
paralogs/NNS
in/IN
human/JJ
./.
====================
Amino/DT
acid/NN
sequence/NN
alignment/NN
of/IN
HP1α/NN
,/,
β/RB
,/,
and/CC
γ/NN
./.
====================
(/(
B/NN
)/)
A/NN
schematic/JJ
diagram/NN
of/IN
the/DT
HP1γ/NN
polypeptide/NN
./.
====================
The/DT
HP1γ/NN
polypeptide/NN
has/VBZ
an/DT
N-terminal/JJ
chromodomain/NN
,/,
a/DT
hinge/NN
domain/NN
,/,
and/CC
C-terminal/JJ
chromoshadow/NN
domain/NN
./.
====================
Interactions/NNS
of/IN
heterochromatin/NN
protein/NN
1/CD
(/(
HP1/NN
)/)
with/IN
a/DT
diversity/NN
of/IN
proteins/NNS
and/CC
its/PRP$
possible/JJ
roles/NNS
(/(
references/VBZ
in/IN
parentheses/NNS
)/)
./.
====================
The/DT
putative/JJ
cellular/JJ
functions/NNS
of/IN
protein-protein/JJ
interactions/NNS
of/IN
HP1/NN
are/VBP
shown/VBN
in/IN
circles/NNS
./.
====================
Some/DT
of/IN
their/PRP$
biological/JJ
significance/NN
is/VBZ
not/RB
yet/RB
clarified/VBN
./.
====================
Only/RB
the/DT
proteins/NNS
that/WDT
have/VBP
been/VBN
shown/VBN
to/TO
interact/VB
with/IN
HP1/NN
in/IN
vivo/FW
are/VBP
listed/VBN
here/RB
./.
====================
Genes/NNS
are/VBP
epigenetically/RB
regulated/VBN
in/IN
cancer/NN
====================
